GlassScriptPhysician profile
Chim Yang
NPI 1447817861
$2,409.86
in general payments reported to CMS, 2019-2025
9 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $338 · 2023: $122 · 2024: $1,584 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007 · Travel and Lodging: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.39 |
| Travel and Lodging | $889.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,129.08 | 2024-2025 | Inspire |
| Davol INC. | $304.21 | 2021-2022 | |
| Abbvie INC. | $290.66 | 2024-2025 | |
| Becton, Dickinson and Company | $275.09 | 2022-2024 | Arista Ah Flexitip |
| Galderma Laboratories, L.P. | $196.16 | 2024 | |
| Genzyme Corporation | $122.07 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $52.56 | 2021-2024 | Dupixent |
| Kaleo, INC. | $25.20 | 2021-2022 | |
| Stryker Corporation | $14.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chim Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.